Biotech | June 10, 2022
Bayer’s Vividion emerging as significant player in San Diego Biotech hub
Bayer now present in four of the largest biotechnology hubs in the United States
Bayer now present in four of the largest biotechnology hubs in the United States
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
Subscribe To Our Newsletter & Stay Updated
